US › Healthcare

Repro Med Systems Inc (KRMD)

US · Healthcare · Medical Instruments & Supplies

$4.24+0.24%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$11.8M
Revenue YoY
+22.1%
Net profit
$-807,078
Profit YoY
+30.8%
EPS
$-0.02
EPS estimate
$-0.01
Net margin
-6.9%

EPS came in at -0.02 against a street estimate of -0.01 — a miss of 100.0%.

Key statistics

Market cap
$188.8M
Forward P/E
188.7
P/B
11.16
Book value
$0.37
EPS (TTM)
$-0.05
52-week high
$6.61
52-week low
$3.20
50-day MA
$4.12
200-day MA
$4.59
Beta
0.41

Analyst view

Analysts rate Repro Med Systems Inc a strong buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $6.80.

Shareholding

Insiders
8.01%
Institutions
56.88%

Largest institutional holders

FundStake
First Light Asset Management, LLC8.20%
Topline Capital Management LLC7.65%
BlackRock Inc5.16%
Vanguard Capital Management, LLC3.67%
Geode Capital Management, LLC2.29%
Simcoe Capital LLC1.77%
Meros Investment Management, LP1.66%
Empire Financial Management Company, LLC1.53%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Repro Med Systems Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.